Prof. Simona Glasberg

EC Member

Neuroendocrine Tumor Unit, ENETS CoE, Division of Medicine, Hadassah Medical Organization and Faculty of Medicine, the Hebrew University of Jerusalem, Israel

A specialist in endocrinology and internal medicine, Prof. Simona Glasberg completed in 2008 a translational fellowship in Neuroendocrine Neoplasms (NENs) and Endocrine Oncology at St. Bartholomew’s Hospital & William Harvey Research Institute, London, UK, exploring the mechanisms by which somatostatin analogues regulate the growth of NENs, and their interaction with mTOR inhibitors. Established as one of the foremost experts in the diagnosis and management of NENs in Israel, Prof. Glasberg is actively involved in both, the care of patients as well as in the research in the field. Her research interest is translational including both clinical studies in NENs patients, as well as basic research assessing the mechanisms of NENs cell proliferation, development of drug resistance and ways to overcoming it, and evaluating new potential markers of heterogeneity in NENs. Prof. Glasberg is the co-chair of the ENETS Carcinoid Heart Disease taskforce and a previous member of ENETS Advisory Board, a previous member of the EC of the Israel Endocrine Society (IES), a previous member of the Executive Committee (EC) of the European Society of Endocrinology (ESE) and Co-Chair of the Rare Diseases Committee. She is a member of European Society for Medical Oncology (ESMO) faculty, was recently appointed as the Endocrine-Related Cancer Focus Area Clinical Lead for ESE, and is an active member of ENETS' MEN1, theranostic, and basic & translational research group taskforces. Moreover, Simona is one of the leaders of ENETS' Women in NET (WIN) initiative.

Prof. Glasberg has published extensively in peer-reviewed journals, is actively involved in the publication of ENETS guidelines, and presented at multiple national and international conferences on the topic of NENs. She is leading the annual national/international post-graduate course in NENs at Hadassah, the bi-annual Israeli Neuroendocrine Neoplasms Congress, being actively involved in the continuous education of new generations of NENs specialists at national and international level.  She is also the Scientific Chair of the Middle East Neuroendocrine Tumor Society (MENETS), the Israeli NENs patient advocacy group. Prof. Glasberg is the recipient of the prestigious 2017 Lindner Prize of the IES, in recognition for her scientific achievements and contribution in the field of NENs. The NET Unit at Hadassah-Hebrew University Medical Center in Jerusalem, under her leadership, has been accredited as an ENETS Center of Excellence, the only one in this field in Israel and the Middle East.


Back to EC